Connecting the dots: The promises of wharton's jelly mesenchymal stem cells for tissue repair and regeneration

Open Tissue Engineering and Regenerative Medicine Journal

Volumn 4, Issue SPEC. ISSUE 1, 2011, Pages 3-5

  la Rocca, Giampiero ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b Istituto Euro Mediterraneo di Scienza e Tecnologia IEMEST   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE INJURY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL ISOLATION; CELL LABELING; CELL POPULATION; COLONY FORMING UNIT F; EDITORIAL; HUMAN; IMMUNOMODULATION; LIVER DISEASE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SCHWANN CELL; TENDON INJURY; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; AMNION CELL; BONE MARROW CELL; CRYOPRESERVATION; EXTRACELLULAR MATRIX; HUMAN CELL; UMBILICAL CORD; WHARTON JELLY;

EID: 84855813775     PISSN: None     EISSN: 18750435     Source Type: Journal    
DOI: 10.2174/1875043501104010003     Document Type: Editorial

References (21)

1. Friedenstein AJ, Gorskaya JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267-74.
2. Taghizadeh RR, Cetrulo KJ, Cetrulo CL. Wharton's jelly stem cells: future clinical applications. Placenta 2011; 32 (Suppl 4): S311-5.
3. Parolini O, Alviano F, Betz AG, et al. Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS). Placenta 2011; 32 (Suppl 4): S285-90.
4. Conconi MT, Di Liddo R, Tommasini M, Calore C, Parnigotto PP. Phenotype and differentiation potential of stromal populations obtained from various zones of human umbilical cord: an overview. Open Tissue Eng Regen Med J 2011; 4: 6-20.
5. Anzalone R, Farina F, Zummo G, La Rocca G. Recent patents and advances on isolation and cellulsr therapy applications of mesenchymal stem cells from human umbilical cord Wharton's jelly. Recent Pat Regen Med 2011; 1: 216-27.
6. Jeschke MG, Gauglitz GG, Phan TT, Herndon DN, Kita K. Umbilical cord lining membrane and Wharton's jelly-derived mesenchymal stem cells: the similarities and differences. Open Tissue Eng Regen Med J 2011; 4: 21-7.
7. Prasanna YS, Jahnavi, VS. Wharton's Jelly mesenchymal stem cells as off-the -shelf cellular therapeutics: A closer look into their regenerative and immunomodulatory properties. Open Tissue Eng Regen Med J 2011; 4: 28-38.
8. Anzalone R, Lo Iacono M, Loria T, et al. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev Rep 2011; 7: 342-63.
9. Tamura M, Kawabata A, Ohta N, Uppalapati L, Becker KG, Troyer D. Wharton's jelly stem cells as agents for cancer therapy. Open Tissue Eng Regen Med J 2011; 4: 39-47.
10. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-9.
11. Anzalone R, Lo Iacono M, Corrao S, et al. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev 2010; 19: 432-38.
12. Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006; 24: 781-92.
13. Scheers I, Lombard C, Najimi M, Sokal EM. Cell therapy for the treatment of metabolic liver disease: an update on the umbilical cord derived stem cells candidates. Open Tissue Eng Regen Med J 2011; 4: 48-53.
14. Kuroda Y, Kitada M, Wakao S, Dezawa M. Mesenchymal stem cells and umbilical cord as sources for Schwann cell differentiation: their potential in peripheral nerve repair. Open Tissue Eng Regen Med J 2011; 4: 54-63.
15. Breymann C, Semonov O. Mesenchymal stem cells derived from Wharton's jelly and their potential for cardio-vascular tissue engineering. Open Tissue Eng Regen Med J 2011; 4: 64-71.
16. Hollweck T, Hartmann I, Eblenkamp M, et al. Cardiac differentiation of human Wharton's jelly stem cells-experimental comparison of protocols. Open Tissue Eng Regen Med J 2011; 4: 95-102.
17. Lo Iacono M, Anzalone R, Corrao S, et al. Perinatal and Wharton's jelly-derived mesenchymal stem cells in cartilage regenerative medicine and tissue engineering strategies. Open Tissue Eng Regen Med J 2011; 4: 72-81.
18. López Y, Seshareddy K, Trevino E, Cox J, Weiss ML. Evaluating the impact of oxygen concentration and plating density on human Wharton's jelly-derived mesenchymal stromal cells. Open Tissue Eng Regen Med J 2011; 4: 82-94.
19. Pierdomenico L, Lanuti P, Lachmann R, et al. Diabetes mellitus during pregnancy interferes with the biological characteristics of Wharton's jelly mesenchymal stem cells. Open Tissue Eng Regen Med J 2011; 4:103-11.
20. Emrani H, Davies JE. Umbilical cord perivascular cells: a mesenchymal cell source for treatment of tendon injuries. Open Tissue Eng Regen Med J 2011; 4: 112-9.
21. Lange-Consiglio A, Corradetti B, Rutigliano L, Cremonesi F, Bizzaro D. In vitro studies of +horse umbilical cord matrix-derived cells: from characterization to labeling for magnetic resonance imaging. Open Tissue Eng Regen Med J 2011; 4: 120-33.